2026 NPPES data Nuclear Cardiology Physician NPI 1710161070 MD
Verify on CMS →

SHAHNAZ BEGUM, MD

Nuclear Cardiology Physician in FRISCO, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
509
Medicare Part D claims · 92 beneficiaries · Nuclear Cardiology Physician avg: 4K
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$16.02
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SHAHNAZ BEGUM, MD is a Nuclear Cardiology Physician ([object Object]) practicing in FRISCO, Texas with a Medicare Part D prescribing footprint of 509 claims across 92 beneficiaries — 9% brand-name prescribing . Industry payments of $16.02 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SHAHNAZ BEGUM, MD filed 509 Medicare Part D claims in 2023 across FRISCO, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

SHAHNAZ BEGUM, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

SHAHNAZ BEGUM, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 12/21/2007

NPI 1710161070

Primary specialty

Nuclear Cardiology Physician

Rare

374 US NPIs in this specialty

Medicare Part D claims

509 87% vs specialty avg

2023 prescription claims

Specialty avg: 4,019

Specialty distribution in Texas

How Nuclear Cardiology Physician compares to other specialties among Texas providers

Texas providers

Nuclear Cardiology Physician share within Texas

1. Nuclear Cardiology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Nuclear Cardiology Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Nuclear Cardiology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Nuclear Cardiology Physician ABMS/AOA estimate

Est. board-certified rate (Nuclear Cardiology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Nuclear Cardiology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SHAHNAZ BEGUM, MD is a Nuclear Cardiology Physician provider practicing in FRISCO, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1710161070. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SHAHNAZ BEGUM, MD appears in the CMS NPPES registry as a Nuclear Cardiology Physician provider holding MD credentials at 14688 STATE HIGHWAY 121 STE 120, FRISCO, TX, 75035, with a listed phone of (469) 910-5558. NPI 1710161070 was issued on 12/21/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BEGUM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 509 prescription claims written by this provider, covering 92 Medicare beneficiaries and totaling roughly $91K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Nuclear Cardiology Physician is a narrow specialty nationwide, with 374 enrolled providers across 37 states and an average of 4,019 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

14688 STATE HIGHWAY 121 STE 120
FRISCO, TX 75035

Provider Details

NPI 1710161070
Specialty Nuclear Cardiology Physician
Credentials MD
Gender Female
NPI Issued 12/21/2007

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SHAHNAZ BEGUM, MD. Source: openpaymentsdata.cms.gov.

Total received

$16

Largest payer

BIOTRONIK INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to SHAHNAZ BEGUM, MD. To verify SHAHNAZ BEGUM, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

SHAHNAZ BEGUM, MD — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 509 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

509
Total Claims
$91K
Total Drug Cost
92
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,399
Total Day Supply
41,861
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$80K
Generic Drug Cost
$11K

Patient Demographics

Average Patient Age
73.9 years
Avg HCC Risk Score
1.57
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Metoprolol Tartrate
71
Amlodipine Besylate
55
Metoprolol Succinate
55
Atorvastatin Calcium
54
Eliquis
Apixaban
35
Losartan Potassium
33
Hydralazine Hcl
29
Lisinopril
17
Rosuvastatin Calcium
16
Carvedilol
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Nuclear Cardiology Physician Overview

How SHAHNAZ BEGUM, MD fits within the Nuclear Cardiology Physician landscape nationally.

374
Nuclear Cardiology Physician Providers in US
37
States with Nuclear Cardiology Physician
4,019
Avg Claims per Provider

SHAHNAZ BEGUM, MD's 509 claims are below the specialty average of 4,019.

Nearby Nuclear Cardiology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BEGUM.

Compare Nuclear Cardiology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SHAHNAZ BEGUM, MD's specialty?
SHAHNAZ BEGUM, MD specializes in Nuclear Cardiology Physician and practices in FRISCO, Texas. Credentials: MD.
How much does SHAHNAZ BEGUM, MD prescribe under Medicare Part D?
In 2023, SHAHNAZ BEGUM, MD wrote 509 Medicare Part D claims totaling $91K in drug costs for 92 beneficiaries.
Where is SHAHNAZ BEGUM, MD located?
SHAHNAZ BEGUM, MD is located at 14688 STATE HIGHWAY 121 STE 120, FRISCO, TX, 75035. Phone: (469) 910-5558.
What is SHAHNAZ BEGUM, MD's NPI number?
SHAHNAZ BEGUM, MD's National Provider Identifier (NPI) is 1710161070, issued on 12/21/2007.
Does SHAHNAZ BEGUM, MD prescribe more brand-name or generic drugs?
SHAHNAZ BEGUM, MD's prescribing is 9% brand-name and 91% generic drugs by claim count, with $80K in brand drug costs.
How many Nuclear Cardiology Physician providers are there in the US?
There are 374 Nuclear Cardiology Physician providers across 37 states in the US. The average Nuclear Cardiology Physician provider writes 4,019 Medicare Part D claims per year.
What drugs does SHAHNAZ BEGUM, MD prescribe most often?
Based on 2023 Medicare Part D data, SHAHNAZ BEGUM, MD's most frequently prescribed drugs include Metoprolol Tartrate, Amlodipine Besylate, Metoprolol Succinate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SHAHNAZ BEGUM, MD accept Medicare?
SHAHNAZ BEGUM, MD appears in CMS Medicare data with 509 Part D claims and 92 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SHAHNAZ BEGUM, MD's credentials?
SHAHNAZ BEGUM, MD's NPI is 1710161070 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology